Fig. 3. Kaplan-Meier analyses of biochemical recurrence (BCR)-free survival rates according to ADCmeanvalues among the total subjects (A) and among the.

Slides:

Advertisements

Similar presentations

to identify the activities of students during their free time. to investigate the method of study among students. to investigate the method of study.

Advertisements

Development and Clinical Validation of a Real-Time PCR Assay for PITX2 DNA Methylation to Predict Prostate-Specific Antigen Recurrence in Prostate Cancer.

Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype. Radiologic assessment in triple-negative breast cancer (A), HER2-positive.

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer Wu-Wei Lai, MD, Fen-Fen Chen, MD,

Volume 155, Issue 3, Pages (March 1996)

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach,

74-year-old man with stage T2a Gleason score prostate cancer (prostate specific antigen = ng/mL) in right transition zone (TZ) with history.

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment Liver.

Oncol Res Treat 2016;39: DOI: /

New perioperative risk factors for biochemical recurrence after robotic assisted radical prostatectomy: A single surgeon experience in high volume Canadian.

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis K.

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Fig. 5. Receiver operating characteristic curve analyses showing diagnostic accuracy of ADC value for differentiating between bland and malignant PVT.Area.

Volume 60, Issue 6, Pages (December 2011)

Volume 70, Issue 2, Pages (August 2016)

Volume 72, Issue 5, Pages (November 2017)

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Quantitative Fluorescence in Situ Hybridization and its Ability to Predict Bladder Cancer Recurrence and Progression to Muscle-Invasive Bladder Cancer

Nat. Rev. Urol. doi: /nrurol

Volume 67, Issue 3, Pages (March 2015)

Postthrombotic or non-postthrombotic severe venous insufficiency: Impact of removal of superficial venous reflux with or without subcutaneous fasciotomy

Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.

European Urology Oncology

L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L

Development and Clinical Validation of a Real-Time PCR Assay for PITX2 DNA Methylation to Predict Prostate-Specific Antigen Recurrence in Prostate Cancer.

Volume 185, Issue 2, Pages (February 2011)

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Volume 66, Issue 2, Pages (August 2014)

Volume 70, Issue 2, Pages (August 2016)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Appendectomy is followed by increased risk of Crohn's disease

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach,

Leonardo P. de Carvalho et al. BTS 2018;3:

Volume 71, Issue 5, Pages (May 2017)

Andrea S. Wolf, MD, MPH, Scott J

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non–Small-Cell Lung Cancer Jung-Jyh Hung, MD,

European Urology Oncology

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

• Kaplan-Meier analyses of (A) overall survival (OS) of the whole cohort (n=173), (B) OS from time of diagnosis of high-risk melanoma among those who remained.

Enrollment and Outcomes

Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review Alexey Surov, Hans Jonas Meyer, Andreas.

A limited and customized follow-up seems justified after endovascular abdominal aneurysm repair in octogenarians Linda Visser, MD, Robert A. Pol, MD,

Examination of Gene Fusion Status in Archival Samples of Alveolar Rhabdomyosarcoma Entered on the Intergroup Rhabdomyosarcoma Study-III Trial Frederic.

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Volume 54, Issue 1, Pages (July 2008)

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer Wu-Wei Lai, MD, Fen-Fen Chen, MD,

Volume 50, Issue 6, Pages (December 2006)

Fernando P. Secin, Fernando J. Bianco, Nicholas T

Kaplan-Meier analysis for the MACE-free or VA-free survival in patients with definite CS (A and C) or suspected CS (B and D) stratified by localisation.

Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma.

Figure 2 Kaplan-Meier survival graphs for 10-year risks of overall and post-90-day recurrent ischemic stroke (IS) and death Kaplan-Meier survival graphs.

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Kaplan-Meier One Minus Survival plot showing cumulative progression to clinical arthritis for patients with clinically suspect arthralgia divided in four.

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Propensity Score Analysis Comparing Videothoracoscopic Lobectomy With Thoracotomy: A French Nationwide Study Pierre-Benoit Pagès, MD, PhD, Jean-Philippe.

Role of Positron Emission Tomography/Computed Tomography Findings for Adjuvant Chemotherapy Indications in Stage T1b-2aN0M0 Lung Adenocarcinoma Shinsuke.

Fig. 1. Kaplan-Meier curves for PFS and OS

Kaplan-Meier survival curve for CVD mortality among physically active and inactive type 2 diabetic patients stratified by baseline hs-CRP levels. Kaplan-Meier.

European Urology Oncology

MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence Akira Ohgami, MD, Tohru Tsuda, MD, Toshihiro Osaki,

Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.

Predictive value of the FGFR3 mutation assay increases with multiple consecutive FGFR3-positive urine samples. Predictive value of the FGFR3 mutation assay.

• Kaplan-Meier analyses of (A) time-to-recurrence (TTR) for the subgroup of patients with high-risk melanoma who had relapsed (n=82), (B) recurrence-free.

European Urology Oncology

Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier plots. Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier.

Fig. 2. Kaplan-Meier plots for PFS and OS of 37 patients according to histological diagnosis (A and D), the extent of tumor resection (B and E), and adjuvant.

Overall and recurrence-free survival.

Kaplan-Meier curves showing the probability of symptom-free survival according to the rate of heart rate rise during exercise testing in (A) for the whole.

Presentation transcript:

Fig. 3. Kaplan-Meier analyses of biochemical recurrence (BCR)-free survival rates according to ADCmeanvalues among the total subjects (A) and among the 4 different subgroups: pathologic Gleason score ≤7 (B), pathologic Gleason score ≥8 (C), pathologic stage ≤ T2 (D), and pathologic stage ≥ T3 (E). Group A, patients with ADC values <746×10−6 mm2/s; group B, patients with ADC values ≥746×10−6 mm2/s.; ADC, apparent diffusion coefficient. Fig. 3. Kaplan-Meier analyses of biochemical recurrence (BCR)-free survival rates according to ADCmeanvalues among the total subjects (A) and among the 4 different subgroups: pathologic Gleason score ≤7 (B), pathologic Gleason score ≥8 (C), pathologic stage ≤ T2 (D), and pathologic stage ≥ T3 (E). Group A, patients with ADC values <746×10−6 mm2/s; group B, patients with . . . Investig Clin Urol. 2017 Jan;58(1):12-19. https://doi.org/10.4111/icu.2017.58.1.12